Address And Details

P. O. Box 219078 , Kansas City, MO 64121
Fund Manager Ronald J. Zibelli Jr.
Manager Tenure 9 Months

Strategy And Objective

The Fund s investment objective is to seek capital appreciation. The Fund mainly invests in common stocks of growth companies. Growth companies are companies whose earnings and stock prices are expected to increase at a faster rate than the overall market. These may be newer companies or established companies of any capitalization range that the portfolio managers believe may appreciate in value over the long term. The Fund primarily invests in securities of U.S. issuers but may also invest in foreign securities. The Fund may also invest up to 10% of its net assets in emerging countries, i.e., those that are in the early stages of their industrial cycles. The portfolio managers look for growth companies with stock prices that they believe are reasonable in relation to overall stock market valuations. In seeking broad diversification of the Fund s portfolio among industries and market sectors, the portfolio managers focus on a number of factors that may vary in particular cases and over time. Currently, the portfolio managers look for: companies in business areas that have above-average growth potential; companies with growth rates that the portfolio managers believe are sustainable over time; stocks with reasonable valuations relative to their growth potential. The Fund may sell the stocks of companies that the portfolio managers believe no longer meet the above criteria, but is not required to do so.

Net Asset Value

as of 4:25 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.57%
  • 1 Month
  • +2.39%
  • 3 Months
  • +8.15%
  • 1 Yr Return
  • +29.46%
  • 5 Yr Return
  • +32.95%

Equity Sector Breakdown

Technology 41.16%
RetailTrade 14.16%
IndustrialCyclical 10.25%
Finance 10.10%
NonDurables 6.76%
Services 6.08%
Health 4.42%
ConsumerDurables 0.94%
Energy 0.72%
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.97%
ForeignStocks 5.31%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 221.40 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 2.75 1.39 -1.78
Beta 1.07 1.06 1.07
R Squared 0.92 0.90 0.89
Std Deviation 20.69 16.87 15.20
Sharpe Ratio 1.13 1.24 n/a

Purchase Information

as of 4:26 PM ET 09/16/2021
Minimum Initial $1000
Minimum Additional $50
Minimum Initial IRA $250

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +29.17%
  • +39.93%
+29.17% +39.93%
3 Year
  • +22.22%
  • +22.50%
+22.22% +22.50%
10 Year
  • +15.51%
  • +13.90%
+15.51% +13.90%
Life Of Fund
  • +9.79%
  • +9.58%
+9.79% +9.58%

Top 10 Holdings

Symbol Company Name % Of Assets
AMZN AMAZON COM INC 8.72%
MSFT MICROSOFT CORP 6.54%
GOOG ALPHABET INC CLASS C 6.06%
AAPL APPLE INC 4.58%
FB FACEBOOK INC 4.12%
PYPL PAYPAL HOLDINGS INC 3.86%
MA MASTERCARD INC 2.98%
UNH UNITEDHEALTH GROUP INC 2.18%
AMAT APPLIED MATERIALS INC 2.09%
NVDA NVIDIA CORP 2.04%

Recent Articles from TheStreet

Toys 'R' Us Sells FAO Schwarz as it Reveals Further Debt Refinancing Plans

Toymakers Facing Holiday Challenge Due to Supply-Chain Issues

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter Blue Lead

Twitter to Pay $810M to Settle Holder Suit Over User Engagement

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Starboard Takes Stake in CVS Health Corp.: Report

CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.